Article Text

Download PDFPDF
Dermatological complications and safety of anti-TNF treatments

Statistics from


  • Competing interests: None.

  • Funding: Centocor, Amgen, Wyeth, Immune Control, Celgene, Pharmacare, Incyte, Abbott Labs, Pfizer, Novo Nordisk.

  • Speakers’ Bureau Memberships: Dr A Gottlieb is on the panels of Amgen, and Wyeth Pharmaceuticals

    Current Consulting/Advisory Board Agreements: Dr Alice Gottlieb has agreements with Amgen, Centocor, Wyeth Pharmaceuticals, Celgene, Bristol Myers Squibb, Beiersdorf, Warner Chilcott, Abbott, Roche, Sankyo, Medarex, Kemia, Celera, TEVA, Actelion, UCB, Novo Nordisk, Almirall, Immune Control, RxClinical, Dermipsor, Medacorp, DermiPsor, Can-Fite, Incyte, Pure-Tech, Magen Biosciences

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.